Independent research tool — not a government agency. Official notices govern.Refreshed
GrantsJunctionAmerican funding, sourcedMethodology
OpenResearch announcementOpportunity PAR-28-062

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

National Institutes of Health · Department of Health and Human Services

At a glance

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional) is an open federal cooperative agreement opportunity from the National Institutes of Health (Department of Health and Human Services). Applications are due January 25, 2027. Applicant types listed as eligible include independent school districts, public colleges & universities, 501(c)(3) nonprofits, nonprofits without 501(c)(3) status and others (see notice). Cost sharing is not required. It is funded under Assistance Listing 93.399 (Cancer Control).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

  1. Aug 31, 2026Posted
  2. Jan 25, 2027Application deadlinenext date
  3. Sep 1, 2026 (est.)Est. award date
  4. Mar 26, 2027Archived
Posted
Aug 31, 2026
Close date
Jan 25, 2027
Archive date
Mar 26, 2027
Est. award date
Sep 1, 2026
Award floor
Not specified
Award ceiling
Not specified
Est. total funding
Not specified
Expected awards
Not specified
Cost sharing
Not required
Funding instrument
Cooperative Agreement
Opportunity category
Discretionary

Typical awards for this program (SAM.gov listing for ALN 93.399, not this notice): NA

Who can apply

  • Independent school districts
  • Public colleges & universities
  • 501(c)(3) nonprofits
  • Nonprofits without 501(c)(3) status
  • Others (see notice)

Additional information on eligibility (from the notice)

Other Eligible ApplicantsEligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that invites applications from eligible organizations to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the applications will be peer-reviewed, and only meritorious applications will be considered for funding. This funding opportunity seeks to support the Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI). The CAPRI Program establishes and strengthens comprehensive, mutually beneficial and meaningful partnerships between Resource Limited Institutions (RLIs) and NCI-designated Cancer Centers (CCs) to accelerate collaborative and innovative cancer. The Program achieves this by strategically building institutional capacity, advancing research capabilities, enhancing the impact of innovative cancer research, cultivating the next generation of Early-Stage Investigators and trainees, and implementing coordinated outreach and education initiatives that extend the benefits of research to all populations nationwide.

Full announcement & documents

The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.

How to apply

0 of 8 done · progress saved in this browser

Assistance Listing

What is an ALN?

Reported obligations under ALN 93.399

Historical data · not a prediction
FY24—
FY25—
FY26— est.
Source: SAM.gov Assistance Listing 93.399. Program-wide totals, not awards from this specific opportunity.

Who was funded under ALN 93.399

Historical data · not a prediction

Since October 1, 2023, 151 grant awards had funding actions under Cancer Control, with 692 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.

  1. ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.$50.2M
  2. NRG ONCOLOGY FOUNDATION INC$41.8M
  3. ALLIANCE NCTN FOUNDATION$26.7M
  4. UNIVERSITY OF ROCHESTER$17.9M
  5. FRED HUTCHINSON CANCER CENTER$17.2M
Recipients, states, recent awards and sub-awards →Source: USAspending.gov.

Agency contact (as published)

National Institutes of Health
nci-crchd@mail.nih.gov
301-402-2541

Quick answers

When is the deadline for this opportunity?

According to the official notice, applications are due January 25, 2027. Confirm the deadline and submission time on Grants.gov before applying.

Who is eligible to apply for this opportunity?

The official notice names these applicant types as eligible: Independent school districts, Public colleges & universities, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status and Others (see notice). Additional restrictions may apply; review the full notice.

How do I apply for this opportunity?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity PAR-28-062), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.